Details
Stereochemistry | MIXED |
Molecular Formula | C15H19NO3 |
Molecular Weight | 261.3163 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC=C(C=C1)C2CCCC(C2)=NO
InChI
InChIKey=IQPPOXSMSDPZKU-PEZBUJJGSA-N
InChI=1S/C15H19NO3/c1-10(15(17)18)11-5-7-12(8-6-11)13-3-2-4-14(9-13)16-19/h5-8,10,13,19H,2-4,9H2,1H3,(H,17,18)/b16-14-
Molecular Formula | C15H19NO3 |
Molecular Weight | 261.3163 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1931475
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1931475
XIMOPROFEN, an arylpropionic acid group member, is a potent non-steroidal anti-inflammatory agent. Its efficacy was studied in several clinical trials in patients with rheumatic diseases.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states. | 1991 |
|
Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients. | 1991 Aug |
|
Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study. | 1994 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7973477
30 mg daily.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:31:48 GMT 2023
by
admin
on
Fri Dec 15 16:31:48 GMT 2023
|
Record UNII |
YFD6WRV4J1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000079378
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
YFD6WRV4J1
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
DTXSID40874686
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL1099272
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
56187-89-4
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
C061944
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
C152934
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
48521
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
SUB00113MIG
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
4219
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
68756
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | |||
|
m11545
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY | Merck Index | ||
|
260-041-7
Created by
admin on Fri Dec 15 16:31:48 GMT 2023 , Edited by admin on Fri Dec 15 16:31:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |